glp-1 inflammatory bowel disease Taming the fires The alleviating effect and mechanism

Screening of therapeutic targets of L-carnitine Well-documented pharmacological targets of L-carnitine were obtained using the following databases: Drugbank, [] SuperPred, [] PharmMapper, [] Therapeutic Target Database, [] and Swiss Target Prediction

The condition affects roughly 1 to 3% of the general adult population, with peak incidence occurring between ages 30 and 50

Clinical trial design This was an investigator-initiated, phase 2, open-label, single-arm trial testing the efficacy of combination nivolumab plus ipilimumab in patients with locally advanced or metastatic RMC

In our study, although adiponectin remained unchanged under Ex-4, secretion of another adipokine irisin was significantly increased

Carr BR, Parker CR, MacDonald PC, Simpson ER: Metabolism of high density lipoprotein by human fetal adrenal tissue